Home › Sickle Cell Disease › Florida
Sickle Cell Disease clinical trials in Florida
9 studies for Sickle Cell Disease are looking for participants at sites in Florida.
Cities in Florida
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- University of Florida, Jacksonville
RecruitingPhase 3
Ages 12 to 100 · All sexes · Updated Sep 28, 2026 · NCT06439082A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Memorial Healthcare, Hollywood
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 17, 2026 · NCT06612268A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- Edward Jenner Research Group LLC., Plantation
- Pediatric Hematology / Oncology a division of Kidz Medical services, West Palm Beach
- St. Mary's Medical Center, West Palm Beach
RecruitingPhase 2/3
Ages 12 and older · All sexes · Updated Aug 18, 2026 · NCT05431088ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- University of Florida Hemophilia Treatment Center, Gainesville
- University of Miami Comprehensive Hemophilia Treatment Center, Miami
- University of Miami Hospital and Clinics, Miami
- and 4 more
RecruitingObservational study
All ages · All sexes · Updated Aug 17, 2026 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- Golisano Children's Hospital, Fort Myers
- The Foundation for Sickle Cell Disease, Hollywood
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Aug 14, 2026 · NCT06699849Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- The Foundation for Sickle Cell Disease, Hollywood
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT07224360The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- Oncology & Hematology Associates of West Broward- Site Number : 8400029, Coral Springs
- Sylvester Comprehensive Cancer Center- Site Number : 8400020, Miami
RecruitingPhase 3
Ages 10 to 65 · All sexes · Updated Jul 29, 2026 · NCT06975865Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
- University of Florida, Gainesville
RecruitingPhase 2
6 Months – 21 Years · All sexes · Updated Jul 27, 2026 · NCT02675959A Long-term Follow-up Study in Patients Who Received BEAM-101
- Mayo Clinic Florida, Jacksonville
RecruitingObservational study
Ages 14 to 37 · All sexes · Updated Jan 28, 2026 · NCT07373639From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.